14
Dec
2026
Pharmaline
Exhibitor at CPHI Middle East 2026 stand H1.W39
About Us
Categories
-
Country/Region:Lebanon
-
On CPHI since:2022
-
Certificates:3
-
Employees:500 - 999
Company types
Event information
CPHI Middle East 2026
-
14 Dec 2026 - 16 Dec 2026
-
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
-
Visit us at stand H1.W39
Products Featured at CPHI Middle East 2026
-
Product Empagliflozin
Empagliflozin is used to treat type 2 diabetes in adult patients. Empaza helps reducing the level of sugar in your blood by blocking the SGLT-2 protein in your kidneys.
Empagliflozin is also indicated for the treatment of heart failure in adult patients with symptoms due to a weak pump function of... -
Product Empagliflozin
Empagliflozin is used to treat type 2 diabetes in adult patients. It helps reducing the level of sugar in your blood by blocking the SGLT-2 protein in your kidneys.
It is also indicated for the treatment of heart failure in adult patients with symptoms due to a weak pump function of the heart.
... -
Product Empagliflozin/Metformin
Empagliflozin/Metformin to control blood sugar levels in adult patients with a form of diabetes called ‘type 2 diabetes mellitus’. Along with diet and exercise, this medicine lowers the amount of sugar in your blood.
Available in the following dosages:
- 60 film-coated tablets/box. Each fil... -
Product Empagliflozin/Metformin
Empagliflozin and Metformin work together to control blood sugar levels in adult patients with a form of diabetes called ‘type 2 diabetes mellitus’. Along with diet and exercise, this medicine lowers the amount of sugar in your blood.
Available in the following dosages:
- 60 film-coat... -
Product Linagliptin
Linagliptin film-coated tablet is a dipeptyl peptidase-4 inhibitor (DPP-4 I) that lowers blood sugar levels in adult patients with type 2 diabetes. This medicine reduce the level of sugar in your blood.
Available in 30 film-coated tablets per box. Each box containing 5mg of Linagliptin.
